Home » About Us » Our Staff » Turna Ray

Turna Ray

Senior Editor
Phone Number
+1-212-651-5626
Email
tray@genomeweb.com

Turna Ray has been covering the personalized medicine and molecular diagnostics industries for GenomeWeb since 2006. She closely tracks the evolving regulatory, reimbursement, and business environment for precision medicine products. 

Articles Authored by Turna Ray

Jun 22, 2018

Some Stakeholders Not on Board With Draft Bill on New Dx Regulatory Framework

Premium

Seventeen organizations don't support the Diagnostic Accuracy and Innovation Act as written and would like lawmakers to advance a CLIA-centric framework.


Jun 20, 2018

Merck KGaA Advancing Tepotinib in MET-Altered Cancer Subpopulations

Premium

The German drugmaker plans to advance the NSCLC treatment in parallel with tissue-based and liquid biopsy companion assays that can identify best responders.

Jun 14, 2018

Janssen Plans Year-End Erdafitinib Filing Based on Phase II Data in FGFR-Mutated Bladder Cancer

Premium

The company is planning to submit the drug and a companion diagnostic that can identify patients with FGFR alterations with the FDA in the second half of 2018.

Jun 13, 2018

Researchers Predict Classification of Thousands of BRCA1/2 Missense Variants Using In Silico Models

Premium

In a publication last week, researchers described efforts to improve in silico methods for investigating the pathogenicity of missense BRCA1/2 variants of unknown significance.

Jun 05, 2018

WIN Consortium Applies Transcriptomics to Bolster Patient Matching in Precision Oncology Study

Premium

At ASCO, researchers presented on the WINTHER trial, which despite setbacks showed that both DNA and RNA analysis can be used to guide personalized treatment strategies.

Jun 04, 2018

At ASCO, FDA Discusses Use of Real-World Data Drawn From Flatiron Health's Clinico-Genomics Database

Premium

This data is helping the agency understand how precision oncology drugs and tests are prescribed outside of clinical trials and in the broader cancer community.

Jun 03, 2018

ASCO Study Shows Modest Efficacy of PI3 Kinase Inhibitor in Molecularly Defined Breast Cancer

Premium

Based on the results of the SANDPIPER study in advanced, PIK3CA-mutated breast cancer, Genentech has decided not to advance development of the PI3 kinase inhibitor taselisib.

Jun 03, 2018

NCI-MATCH Researchers Discuss First Data From Three Treatment Arms at ASCO

Premium

Researchers found that some molecularly defined subsets of patients responded to targeted drugs while others didn't.

May 30, 2018

Stakeholders Urge Payors to Cover Confirmatory Testing for 23andMe's DTC BRCA Test

Premium

The Center for Genomic Interpretation and NSGC want payors to cover confirmatory testing for patients with positive results from 23andMe's FDA-cleared test.

May 29, 2018

Myriad Genetics Adds Reproductive Tests With Counsyl Buy, Lessens Hereditary Cancer Competition

Premium

The $375 million deal marks the integration of Myriad, a leader in the hereditary cancer genetic screening market, with Counsyl, a leader in reproductive genetic screening.

The Scan

Privacy Policy Information, Please

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

Moving the Parts About

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

This Week in Science

In Science this week: genetic overlap among many psychiatric disorders, and more.

Just Skip that Step

The Economist writes that an increasing number of scientific journals don't do peer review.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.